Dr. Chamindra Laverty, MD
Claim this profileUniversity of California San Diego
Studies Muscular Dystrophy
Studies Duchenne Muscular Dystrophy
5 reported clinical trials
6 drugs studied
Area of expertise
1Muscular Dystrophy
dystrophin positive
DMD negative
DMD positive
2Duchenne Muscular Dystrophy
dystrophin positive
DMD negative
DMD positive
Affiliated Hospitals
Clinical Trials Chamindra Laverty, MD is currently running
Gene Therapy
for Duchenne Muscular Dystrophy
The study will evaluate the safety and efficacy of delandistrogene moxeparvovec gene transfer therapy in non-ambulatory and ambulatory males with DMD. This is a randomized, double-blind, placebo-controlled 2-part study. Participants will be in the study for approximately 128 weeks. All participants will have the opportunity to receive intravenous (IV) delandistrogene moxeparvovec in either Part 1 or Part 2.
Recruiting1 award Phase 35 criteria
Cell Therapy
for Duchenne Muscular Dystrophy
This trial tests a cell therapy called CAP-1002 in boys and young men with Duchenne muscular dystrophy. The therapy involves giving special cells through an IV to help improve muscle function. The goal is to see if this treatment can repair or regenerate damaged muscles.
Recruiting1 award Phase 31 criteria
More about Chamindra Laverty, MD
Clinical Trial Related1 year of experience running clinical trials · Led 5 trials as a Principal Investigator · 5 Active Clinical TrialsTreatments Chamindra Laverty, MD has experience with
- Placebo
- DYNE-251
- SRP-9001 (Delandistrogene Moxeparvovec)
- CAP-1002
- Bidridistrogene Xeboparvovec (SRP-9003)
- Establishing Biomarkers And Clinical Endpoints
Breakdown of trials Chamindra Laverty, MD has run
Muscular Dystrophy
Duchenne Muscular Dystrophy
Muscle Disease
Disuse Atrophy
Neuro-Oncology
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Chamindra Laverty, MD specialize in?
Chamindra Laverty, MD focuses on Muscular Dystrophy and Duchenne Muscular Dystrophy. In particular, much of their work with Muscular Dystrophy has involved dystrophin positive patients, or patients who are DMD negative.
Is Chamindra Laverty, MD currently recruiting for clinical trials?
Yes, Chamindra Laverty, MD is currently recruiting for 4 clinical trials in La Jolla California. If you're interested in participating, you should apply.
Are there any treatments that Chamindra Laverty, MD has studied deeply?
Yes, Chamindra Laverty, MD has studied treatments such as Placebo, DYNE-251, SRP-9001 (Delandistrogene Moxeparvovec).
What is the best way to schedule an appointment with Chamindra Laverty, MD?
Apply for one of the trials that Chamindra Laverty, MD is conducting.
What is the office address of Chamindra Laverty, MD?
The office of Chamindra Laverty, MD is located at: University of California San Diego, La Jolla, California 92037 United States. This is the address for their practice at the University of California San Diego.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.